L 2 ‐ FROM THE α2‐ADRENOCEPTORS TO THE IMIDAZOLINE PREFERRING RECEPTORS
暂无分享,去创建一个
M. Dontenwill | J. Stutzmann | G. Bricca | H. Greney | J. Feldman | P. Bousquet | A. Belcourt | E. Tibirica
[1] M. Dontenwill,et al. Production and characterization of an iminoimidazolidine specific monoclonal antibody using para-aminoclonidine as antigen. , 1992, Life sciences.
[2] F. Gonon,et al. Selectivity of rilmenidine for the nucleus reticularis lateralis, a ventrolateral medullary structure containing imidazoline-preferring receptors. , 1991, European journal of pharmacology.
[3] F. Tesson,et al. Identification of an imidazoline-guanidinium receptive site in mitochondria from rabbit cerebral cortex. , 1991, European journal of pharmacology.
[4] F. Gonon,et al. An imidazoline-specific mechanism for the hypotensive effect of clonidine: a study with yohimbine and idazoxan. , 1991, The Journal of pharmacology and experimental therapeutics.
[5] J. Pégorier,et al. Subcellular distribution of imidazoline-guanidinium-receptive sites in human and rabbit liver. Major localization to the mitochondrial outer membrane. , 1991, The Journal of biological chemistry.
[6] D. Atlas,et al. Imidazoline receptors in rat liver cells: A novel receptor or a subtype of α2-adrenoceptors? , 1990 .
[7] M. Dontenwill,et al. PostersPartial purification of the human endazoline, the specific endogenous ligand for imidazoline-preferring receptors , 1990 .
[8] M. Dontenwill,et al. Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit , 1990, British journal of pharmacology.
[9] J. Wikberg,et al. Further Characterization of the Guinea Pig Cerebral Cortex Idazoxan Receptor: Solubilization, Distinction from the Imidazole Site, and Demonstration of Cirazoline as an Idazoxan Receptor‐Selective Drug , 1990, Journal of neurochemistry.
[10] A. Parini,et al. Effect of imidazolines on Na+ transport and intracellular pH in renal proximal tubule cells. , 1990, Biochimica et biophysica acta.
[11] T. Ishikawa,et al. Binding of [3H]p-aminoclonidine to two sites, α2-adrenoceptors and imidazoline binding sites: distribution of imidazoline binding sites in rat brain , 1990, Brain Research.
[12] D. Reis,et al. Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. , 1990, The Journal of pharmacology and experimental therapeutics.
[13] D. Atlas,et al. Imidazoline-guanidinium receptive site in renal proximal tubule: asymmetric distribution, regulation by cations and interaction with an endogenous clonidine displacing substance. , 1990, The Journal of pharmacology and experimental therapeutics.
[14] R. Graham,et al. Characterization of an imidazoline/guanidinium receptive site distinct from the alpha 2-adrenergic receptor. , 1989, The Journal of biological chemistry.
[15] M. Berlan,et al. Human fat cell alpha-2 adrenoceptors. II. Comparative study of partial and full agonist binding parameters using [3H]clonidine and [3H]UK-14,304. , 1989, The Journal of pharmacology and experimental therapeutics.
[16] M. Dontenwill,et al. Rilmenidine selectivity for imidazoline receptors in human brain. , 1989, European journal of pharmacology.
[17] M. Dontenwill,et al. The imidazoline preferring receptor: binding studies in bovine, rat and human brainstem. , 1989, European journal of pharmacology.
[18] D. Langin,et al. [3H]Idazoxan binding at non-α2-adrenoceptors in rabbit adipocyte membranes , 1989 .
[19] D. Langin,et al. [3H]idazoxan binding at non-alpha 2-adrenoceptors in rabbit adipocyte membranes. , 1989, European journal of pharmacology.
[20] D. Reis,et al. Hypotensive action of clonidine analogues correlates with binding affinity at imidazole and not alpha‐2-adrenergic receptors in the rostral ventrolateral medulla , 1988, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[21] M. Dontenwill,et al. Evidence for the existence of a homogeneous population of imidazoline receptors in the human brainstem. , 1988, European journal of pharmacology.
[22] M. Dontenwill,et al. Production and characterization of anti-clonidine antibodies not cross-reacting with catecholamines. , 1988, European journal of pharmacology.
[23] J. Feldman,et al. Differences in the ability of yohimbine to antagonize the hypotensive effect of clonidine in normotensive and spontaneously hypertensive anesthetized rats. , 1988, The Journal of pharmacology and experimental therapeutics.
[24] B. Letac,et al. A multicenter double-blind comparative study of rilmenidine and clonidine in 333 hypertensive patients. , 1988, The American journal of cardiology.
[25] J. Reid,et al. [3H]yohimbine and [3H]idazoxan bind to different sites on rabbit forebrain and kidney membranes. , 1988, European journal of pharmacology.
[26] P. Laduron. Stereospecificity in binding studies. A useful criterion though insufficient to prove the presence of receptors. , 1988, Biochemical pharmacology.
[27] R. Podevin,et al. Evidence for imidazoline binding sites in basolateral membranes from rabbit kidney. , 1987, Biochemical and biophysical research communications.
[28] D. Reis,et al. Clonidine binds to imidazole binding sites as well as alpha 2-adrenoceptors in the ventrolateral medulla. , 1987, European journal of pharmacology.
[29] D. Reis,et al. An endogenous clonidine-displacing substance from bovine brain: receptor binding and hypotensive actions in the ventrolateral medulla. , 1986, Life sciences.
[30] J. Schwartz,et al. Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines. , 1984, The Journal of pharmacology and experimental therapeutics.
[31] F. Gonon,et al. Catecholamine metabolism in the rat locus coeruleus as studied by in vivo differential pulse voltammetry. I. Nature and origin of contributors to the oxidation current at +0.1v , 1983, Brain Research.
[32] J. Schwartz,et al. Alpha-adrenergic drugs. Pharmacological tools for the study of the central vasomotor control. , 1983, Biochemical pharmacology.
[33] P. Timmermans,et al. alpha 2 adrenoceptors: classification, localization, mechanisms, and targets for drugs. , 1982, Journal of medicinal chemistry.
[34] G. Aghajanian,et al. alpha 2-adrenoceptor-mediated hyperpolarization of locus coeruleus neurons: intracellular studies in vivo. , 1982, Science.
[35] J. Schwartz,et al. The nucleus reticularis lateralis: a region highly sensitive to clonidine. , 1981, European journal of pharmacology.
[36] W. Kobinger. Central α-adrenergic systems as targets for hypotensive drugs , 1978 .
[37] Kobinger. Central alpha-adrenergic systems as targets for hypotensive drugs. , 1978, Reviews of physiology, biochemistry and pharmacology.
[38] H. Schmitt. The Pharmacology of Clonidine and Related Products , 1977 .
[39] J. Feldman,et al. Role of the ventral surface of the brain stem in the hypotensive action of clonidine. , 1975, European journal of pharmacology.